Press Releases
2021 Press Releases
- January 22: Cholangiocarcinoma Foundation Celebrates 15th Anniversary
- January 18: Cholangiocarcinoma Foundation Launches Trusted Partners Program
- February 24: Cholangiocarcinoma Foundation partners with Japan Cholangiocarcinoma Association to Increase Global Advocacy for Bile Duct Cancer
- March 1: Cholangiocarcinoma Foundation Hails Milestone in Effort to Advance new Treatment for IDH1-positive Cholangiocarcinoma Patients as Agios Announces New FDA Filing for TIBSOVO®
- April 1: Cholangiocarcinoma Foundation Presents First-Ever Poster Awards
- April 1: CCF is pleased to award the 2021 Mark R. Clements Award to Renuka Iyer and Lisa Craine
- April 1: Cholangiocarcinoma Foundation Awards $300,000 in Research Grants to Fund Early Career Investigators at Renowned Institutions
- May 6: Cholangiocarcinoma Foundation Celebrates FDA’s Filing Acceptance and Priority Review of TIBSOVO® for The Treatment Of IDH1-mutated Cholangiocarcinoma Patients
2020 Press Releases
- February 11: February 12th is World Cholangiocarcinoma Day
- March 9: The Cholangiocarcinoma Foundation's Annual Conference Will Now Be a Virtual Event
- June 4: CCF Wants You to Move for a Cure
- July 7: Cholangiocarcinoma Foundation Consortium Moves to Clarify and Promote Consistent Use of Common Terms for Biomarker and Germline Genetic Testing
- October 9: 2021 Cholangiocarcinoma Annual Conference to be held March 31 Through April 2, 2021
- October 16: CCF wants you to join it’s first ever Turkey Trot
- November 20: Stacie Lindsey to Receive Luminary Award for Advances in GI Cancers
- December 3: Cholangiocarcinoma Foundation celebrates FDA’s Acceptance Of New Drug Application For Infigratinib For The Treatment Of Cholangiocarcinoma
- December 10: Cholangiocarcinoma Foundation celebrates FDA’s Breakthrough Therapy Designation for Zanidatamab in Patients with Biliary Tract Cancer
2019 Press Releases
- February 15: The Cholangiocarcinoma Foundation Announces New Scientific and Medical Advisory Board
- February 21: Helping Bile Duct Cancer Patients Find Specialists Nationwide
- August 6: Cholangiocarcinoma Foundation Awards $365k in Research Fellowship Grants in Largest Funding Cycle to Date
- September 10: AMMF, Cholangiocarcinoma Foundation, TargetCancer Foundation, and The Bili Project, Award Unique Collaborative Grant
- October 3: CCF Comes to Chicago
2018 Press Releases
- January 12: Patient-Centered Outcomes Research Institute Awards $50,000 to the Cholangiocarcinoma Foundation for Upcoming Conference
- January 18: Five Biopharma Companies Headline Industry Forum at Cholangiocarcinoma Foundation Annual Conference
- May 9: Cholangiocarcinoma Foundation Partners with Komodo Health to Disrupt Intelligence Gathering in the Fight Against Cancer
- June 14: Bayer awards the Cholangiocarcinoma Foundation Funding for Proposal to Help Patients
- June 18: Cholangiocarcinoma Foundation Launches App to Track Medical History and Improve Care for Patients with Bile Duct Cancer
- August 3: Conquer Cancer Young Investigator Award from Cholangiocarcinoma Foundation & Partners Furthers Immunotherapy Research
- December 19: Vivek Wadhwa Announced as Cholangiocarcinoma Foundation Annual Conference Keynote Speaker
2017 Press Releases
- Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference
- January 6: RedHill Biopharma Announces YELIVA® (ABC294640) Abstract Presentation at the 2017 Cholangiocarcinoma Foundation Annual Conference
- January 12: Delcath Announces Ongoing Patient Treatment And Data Collection In Intrahepatic Cholangiocarcinoma Study Cohort
- January 19: Five Biopharma Companies Headline Industry Night at Cholangiocarcinoma Foundation Annual Conference
- February 3: Leap Therapeutics Presents Biomarker and Efficacy Data at the Cholangiocarcinoma Foundation 2017 Annual Meeting
- March 1: Mindfulness Eases Pain and Stress in Patients with Cholangiocarcinoma and Other Cancers
- March 31: Leap Therapeutics Reports Full Year 2016 Financial Results and Progression-Free Survival Data in Advanced Biliary Tract Cancers
- April 26: Chad M. Walesky, Ph.D., to receive the ASIP 2017 Young Scientist Leadership Award
- May 18: PCI Biotech: First quarter 2017 report and presentation
- June 3: The Cholangiocarcinoma Foundation Awards $150,000 in New Research Grants for 2017
- June 14: Cholangiocarcinoma Patients with a Specific Genetic Biomarker Now have a New Treatment Option
2016 Press Releases
- January 26: Cholangiocarcinoma Foundation Receives $50,000 Award from PCORI
- March 28: Cure Magazine: Cholangiocarcinoma Research is Expanding, But Many Questions Are Still Unanswered
- September 13: Charlie Chanaratsopon, CEO and Founder of “Charming Charlie” Cares
- September 16: Scientists Investigate Improved Treatments and a Cure for Rare Disease – Bile Duct Cancer: Now Accepting Applications for the Cholangiocarcinoma Foundation Research Fellowship Program
- September 27: Award-winning Retailer Teams-up with the Cholangiocarcinoma Foundation to Support Research
- November 9: Saha Laboratory Opens Doors to Study Highly Lethal Cancer of the Bile Ducts
2015 Press Releases
- January 9: The Cholangiocarcinoma Foundation Announces #UNSELFIE Winner and Raises Highest One-Day Donation Total Since Its Founding
- May 30: The Cholangiocarcinoma Foundation Awards $260,000 in Research Grants
- July 11: Kathi Wagner Appointed as Cholangiocarcinoma Foundation's Director of Development
2014 Press Releases
- March 17: The Cholangiocarcinoma Foundation Appoints New Executive Director
- May 1: The Cholangiocarcinoma Foundation and Patient Crossroads Partner to Launch Global Patient Registry in June 2014
- May 30: The Cholangiocarcinoma Foundation Launches “Show Us Your Card” Education Campaign
2013 Press Releases
- February 1: February is Cholangiocarcinoma Awareness Month
2012 Press Releases
- February 1: February is Cholangiocarcinoma Awareness Month
2011 Press Releases
Signup
For newsletters and other breaking news, you can sign-up for e-alerts.
Inquiries
For media inquiries, contact Stacie Lindsey or Jordan Giles.
